Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Separate fact from fiction on obesity with expert insights! Debunk common myths and discover the truth about this complex ...

With the advent of GLP-1 drugs, perspectives about weight management are changing. Ted Kyle hopes the food industry can make some changes, too, to better serve all consumers.

Novo Nordisk on Monday revealed data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

In conclusion, this study shows that being overweight or obese during childhood may increase the chance of developing COPD ...

By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

The reliance on animal model data, particularly in a diet-induced obesity mouse model, raises questions about the applicability and efficacy of the results in human clinical settings. The ...